연구성과로 돌아가기
2023 연구자 정보 (144 / 1135)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Morozov, Viacheslav (Morozov, V) |
Hepatolog Med Co, Samara, Russia |
|
|
[JCR상위 4.5] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Mu, Quanhua (Mu, QH) |
Hong Kong Univ Sci & Technol, Dept Chem & Biol Engn, Kowloon, Clear Water Bay, Hong Kong, Peoples R China |
JKI-6568-2023 Mu, Quanhua |
|
[JCR상위 4.5] Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | SCIE | 4.5 | GENETICS & HEREDITY | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | ||
|
Nam, Yoonhee (Nam, Y) |
제1저자 |
Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Clear Water Bay, Hong Kong, Peoples R China Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Clear Water Bay, Hong Kong, Peoples R China |
|
|
[JCR상위 4.5] Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | SCIE | 4.5 | GENETICS & HEREDITY | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | |
|
Oh, Jeong-Woo (Oh, JW) |
Samsung Med Ctr, Inst Refractory Canc Res, Res Inst Future Med, Seoul, South Korea |
|
|
[JCR상위 4.5] Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | SCIE | 4.5 | GENETICS & HEREDITY | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | ||
|
Pacurar, Daniela (Pacurar, D) |
Carol Davila Univ Med & Pharm, Bucharest, Romania |
IYS-1131-2023 Pacurar, Daniela |
|
[JCR상위 4.5] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Paff, Melanie (Paff, M) |
GSK, Collegeville, PA USA |
|
|
[JCR상위 4.5] INITIAL EXPLORATION OF HEPATITIS B SURFACE ANTIGEN ( HBsAg) BLIPS FOLLOWING BEPIROVIRSEN TREATMENT: A POST HOC ANALYSIS OF THE B- CLEAR STUDY [JCR상위 1.7] Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report |
SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | robert.c.elston@gsk.com; | ||
|
Park, JeongSu (Park, J) |
제1저자 | Chungbuk Natl Univ, Cheongju, South Korea |
|
|
[JCR상위 4.5] ALPHA-1 ANTITRYPSIN/ PROTEINASE 3 IMBALANCE EXERTS PROTEOLYTIC REGULATION ON INTERLEUKIN-32 GAMMA TO PROMOTE NONALCOHOLIC STEATOHEPATITIS | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | ||
|
Park, Jin Kyung (Park, JK) |
Ildong Pharmaceut Co, Seoul, South Korea |
|
|
[JCR상위 4.5] DECREASED RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH BESIFOVIR | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Park, Min Kyung (Park, MK) |
Seoul Natl Univ, Coll Med, Seoul, South Korea Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea |
|
|
[JCR상위 4.5] PROTON PUMP INHIBITOR TREATMENT IS ASSOCIATED WITH A HIGHER MORTALITY IN CIRRHOTIC PATIENTS: A MULTICENTER STUDY [JCR상위 8.7] Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study |
SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | mhhur@snu.ac.kr;alsrud627@snu.ac.kr;terryfungyip@gmail.com;e580306@ms31.hinet.net;vital@snu.ac.kr;dr.choi85@gmail.com;KSUKOREA@yuhs.ac;limys@amc.seoul.kr;psyoung0419@gmail.com;wonglaihung@mect.cuhk.edu.hk;sinndhn@gmail.com;jyj412@hanmail.net;sekim@hallym.or.kr;cypeng@mail.cmuh.org.tw;drshp@khu.ac.kr;5137ccy@gmail.com;hwiyoung@gmail.com;amelia86@naver.com;gandorie@gmail.com;noshin@hanyang.ac.kr;mseileen80@hanyang.ac.kr;sonjh@hanyang.ac.kr;dr486@eulji.ac.kr;jshim3927@gmail.com;jeongsw@schmc.ac.kr;choyk2004.cho@samsung.com;hskim@kdh.or.kr;mjjang2014@naver.com;yoonjun@snu.ac.kr;yoonjh@snu.ac.kr;pindra@empal.com; | ||
|
Park, Seung Ha (Park, SH) |
Inje Univ, Haeundae Paik Hosp, Gimhae, South Korea |
|
|
[JCR상위 4.5] HCC PREDICTION MODELS EFFECTIVELY ASSESS THE RISK OF HCC IN CHRONIC HEPATITIS C PATIENTS WITHOUT ADVANCED FIBROSIS AFTER ORAL ANTIVIRAL THERAPY: A MULTICENTER STUDY | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Park, Sung Jae (Park, SJ) |
Inje Univ, Coll Med, Gimhae, South Korea |
|
|
[JCR상위 4.5] PROTON PUMP INHIBITOR TREATMENT IS ASSOCIATED WITH A HIGHER MORTALITY IN CIRRHOTIC PATIENTS: A MULTICENTER STUDY [JCR상위 4.5] DECREASED RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH BESIFOVIR |
SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Park, Woong-Yang (Park, WY) |
Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea |
|
|
[JCR상위 4.5] Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | SCIE | 4.5 | GENETICS & HEREDITY | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | ||
|
Park, Young Joo (Park, YJ) |
Pusan Natl Univ, Coll Med, Dept Internal Med, Busan, South Korea Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea Pusan Natl Univ Hosp, Busan, South Korea |
|
|
[JCR상위 4.5] REAL-WORLD EXPERIENCE OF ATEZOLIZUMAB PLUS BEVACIZUMAB COMBINATION TREATMENT IN HIGH-RISK PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA [JCR상위 1.7] Real-world experience of atezolizumab plus bevacizumab combination treatment in high risk patients with advanced hepatocellular carcinoma |
SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | jheo@pusan.ac.kr; | ||
|
Piratvisuth, Teerha (Piratvisuth, T) |
Nkc Inst Gastroenterol & Hepatol, Songkhla, Thailand NKC Inst Gastroenterol & Hepatol, Songkhla, Thailand |
|
|
[JCR상위 4.5] INITIAL EXPLORATION OF HEPATITIS B SURFACE ANTIGEN ( HBsAg) BLIPS FOLLOWING BEPIROVIRSEN TREATMENT: A POST HOC ANALYSIS OF THE B- CLEAR STUDY [JCR상위 1.7] Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report |
SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | robert.c.elston@gsk.com; | ||
|
Quinn, Geoff (Quinn, G) |
GSK, Stevenage, Herts, England |
|
|
[JCR상위 4.5] INITIAL EXPLORATION OF HEPATITIS B SURFACE ANTIGEN ( HBsAg) BLIPS FOLLOWING BEPIROVIRSEN TREATMENT: A POST HOC ANALYSIS OF THE B- CLEAR STUDY [JCR상위 1.7] Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report |
SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | robert.c.elston@gsk.com; |
페이지 이동: